57 research outputs found

    Parasite Manipulation of the Invariant Chain and the Peptide Editor H2-DM Affects Major Histocompatibility Complex Class II Antigen Presentation during Toxoplasma gondii Infection

    Get PDF
    Toxoplasma gondii is an obligate intracellular protozoan parasite. This apicomplexan is the causative agent of toxoplasmosis, a leading cause of central nervous system disease in AIDS. It has long been known that T. gondii interferes with major histocompatibility complex class II (MHC-II) antigen presentation to attenuate CD4(+) T cell responses and establish persisting infections. Transcriptional downregulation of MHC-II genes by T. gondii was previously established, but the precise mechanisms inhibiting MHC-II function are currently unknown. Here, we show that, in addition to transcriptional regulation of MHC-II, the parasite modulates the expression of key components of the MHC-II antigen presentation pathway, namely, the MHC-II-associated invariant chain (Ii or CD74) and the peptide editor H2-DM, in professional antigen-presenting cells (pAPCs). Genetic deletion of CD74 restored the ability of infected dendritic cells to present a parasite antigen in the context of MHC-II in vitro. CD74 mRNA and protein levels were, surprisingly, elevated in infected cells, whereas MHC-II and H2-DM expression was inhibited. CD74 accumulated mainly in the endoplasmic reticulum (ER), and this phenotype required live parasites, but not active replication. Finally, we compared the impacts of genetic deletion of CD74 and H2-DM genes on parasite dissemination toward lymphoid organs in mice, as well as activation of CD4(+) T cells and interferon gamma (IFN-Îł) levels during acute infection. Cyst burdens and survival during the chronic phase of infection were also evaluated in wild-type and knockout mice. These results highlight the fact that the infection is influenced by multiple levels of parasite manipulation of the MHC-II antigen presentation pathway

    Fast and Flexible Software Polar List Decoders

    Get PDF
    International audienceFlexibility is one mandatory aspect of channel coding in modern wireless communication systems. Among other things, the channel decoder has to support several code lengths and code rates. This need for flexibility applies to polar codes that are considered for control channels in the future 5G standard. This paper presents a new generic and flexible implementation of a software Successive Cancellation List (SCL) decoder. A large set of parameters can be fine-tuned dynamically without re-compiling the software source code: the code length, the code rate, the frozen bits set, the puncturing patterns, the cyclic redundancy check, the list size, the type of decoding algorithm, the tree-pruning strategy and the data quantization. This generic and flexible SCL decoder enables to explore tradeoffs between throughput, latency and decoding performance. Several optimizations are proposed to achieve a competitive decoding speed despite the constraints induced by the genericity and the flexibility. The resulting polar list decoder is about 4 times faster than a generic software decoder and only 2 times slower than a non-flexible unrolled decoder. Thanks to the flexibility of the decoder, the fully adaptive SCL algorithm can be easily implemented and achieves higher throughput than any other similar decoder in the literature (up to 425 Mb/s on a single processor core for N = 2048 and K = 1723 at 4.5 dB)

    The hydrophobic region of the Leishmania peroxin 14 : requirements for association with a glycosome mimetic membrane

    Get PDF
    This work was funded by operating grants from the Canadian Institutes of Health Research (CIHR) and a Natural Sciences Engineering Research Council of Canada (NSERC) Discovery grant [Fonds de recherche du QuĂ©bec — Nature et technologies (FRQNT) Regroupement StratĂ©gique grant to the Centre for Host-Parasite Interactions (A.J.)]. N.C. was supported by a doctoral research scholarship from FRQNT. E.B. was supported by a Banting postdoctoral fellowship from CIHR. This work was also supported in part by Wellcome Trust grants [086658 and 093228] to T.K.S. C.S. recognizes the financial support from the Natural Sciences and Engineering Research Council of Canada and a Canada Foundation for Innovation grant [16299].Protein import into the Leishmania glycosome requires docking of the cargo-loaded peroxin 5 (PEX5) receptor to the peroxin 14 (PEX14) bound to the glycosome surface. To examine the LdPEX14-membrane interaction, we purified L. donovani promastigote glycosomes and determined the phospholipid and fatty acid composition. These membranes contained predominately phosphatidylethanolamine, phosphatidylcholine, and phosphatidylglycerol (PG) modified primarily with C18 and C22 unsaturated fatty acid. Using large unilamellar vesicles (LUVs) with a lipid composition mimicking the glycosomal membrane in combination with sucrose density centrifugation and fluorescence-activated cell sorting technique, we established that the LdPEX14 membrane-binding activity was dependent on a predicted transmembrane helix found within residues 149-179. Monolayer experiments showed that the incorporation of PG and phospholipids with unsaturated fatty acids, which increase membrane fluidity and favor a liquid expanded phase, facilitated the penetration of LdPEX14 into biological membranes. Moreover, we demonstrated that the binding of LdPEX5 receptor or LdPEX5-PTS1 receptor-cargo complex was contingent on the presence of LdPEX14 at the surface of LUVs.PostprintPeer reviewe

    The Protozoan Parasite Toxoplasma gondii Selectively Reprograms the Host Cell Translatome

    Get PDF
    The intracellular parasite Toxoplasma gondii promotes infection by targeting multiple host cell processes; however, whether it modulates mRNA translation is currently unknown. Here, we show that infection of primary murine macrophages with type I or II T. gondii strains causes a profound perturbation of the host cell translatome. Notably, translation of transcripts encoding proteins involved in metabolic activity and components of the translation machinery was activated upon infection. In contrast, the translational efficiency of mRNAs related to immune cell activation and cytoskeleton/cytoplasm organization was largely suppressed. Mechanistically, T. gondii bolstered mechanistic target of rapamycin (mTOR) signaling to selectively activate the translation of mTOR-sensitive mRNAs, including those with a 5'-terminal oligopyrimidine (5' TOP) motif and those encoding mitochondrion-related proteins. Consistent with parasite modulation of host mTOR-sensitive translation to promote infection, inhibition of mTOR activity suppressed T. gondii replication. Thus, selective reprogramming of host mRNA translation represents an important subversion strategy during T. gondii infection

    Damaged DNA Binding Protein 2 Plays a Role in Breast Cancer Cell Growth

    Get PDF
    The Damaged DNA binding protein 2 (DDB2), is involved in nucleotide excision repair as well as in other biological processes in normal cells, including transcription and cell cycle regulation. Loss of DDB2 function may be related to tumor susceptibility. However, hypothesis of this study was that DDB2 could play a role in breast cancer cell growth, resulting in its well known interaction with the proliferative marker E2F1 in breast neoplasia. DDB2 gene was overexpressed in estrogen receptor (ER)-positive (MCF-7 and T47D), but not in ER-negative breast cancer (MDA-MB231 and SKBR3) or normal mammary epithelial cell lines. In addition, DDB2 expression was significantly (3.0-fold) higher in ER-positive than in ER-negative tumor samples (P = 0.0208) from 16 patients with breast carcinoma. Knockdown of DDB2 by small interfering RNA in MCF-7 cells caused a decrease in cancer cell growth and colony formation. Inversely, introduction of the DDB2 gene into MDA-MB231 cells stimulated growth and colony formation. Cell cycle distribution and 5 Bromodeoxyuridine incorporation by flow cytometry analysis showed that the growth-inhibiting effect of DDB2 knockdown was the consequence of a delayed G1/S transition and a slowed progression through the S phase of MCF-7 cells. These results were supported by a strong decrease in the expression of S phase markers (Proliferating Cell Nuclear Antigen, cyclin E and dihydrofolate reductase). These findings demonstrate for the first time that DDB2 can play a role as oncogene and may become a promising candidate as a predictive marker in breast cancer

    Subversion of MHC-II antigen presentation by «Toxoplasma gondii» involves parasite secretory organelles and the modulation of host immune effectors in the endocytic pathway

    No full text
    The obligate intracellular protozoan parasite Toxoplasma gondii, the causative agent of toxoplasmosis, is a highly ubiquitous pathogen that infects virtually any warm-blooded animal. Although the infection generally remains asymptomatic in healthy individuals, the parasite invariably encysts. It has been shown that T. gondii is able to achieve this goal at least by interfering with MHC-II antigen presentation to dampen the development of the CD4+ T helper cell response and gain a head start on the host adaptive immune system. Previous reports have shown that T. gondii inhibits transcription of MHC-II and several other related genes, but the causative inhibitory molecules have yet to be identified.In an attempt to identify these molecules, a forward genetic screening strategy was initially elaborated, with a genome-wide insertional mutagenesis carried out in order to disrupt the genes encoding for the inhibitory molecules followed. By specifically isolating mutants unable to inhibit MHC-II expression and antigen presentation by flow cytometry, isolation of the disrupted loci and database mining could have enabled the identification by of the encoded inhibitory molecules. However, the screen was not carried out due to experimental limitations.Biochemical analyses were employed to further characterize the MHC-II inhibitory activity, revealing that this activity segregated with the high-speed supernatant (HSS) prepared from sonicated parasites and was enriched with increasing centrifugal speeds. The inhibitory activity was protein dose-dependent and was completely abrogated when the HSS was treated with a broad-spectrum protease. Subcellular fractionation revealed that the inhibitory activity was found in fractions enriched with secretory organelles, specifically rhoptries (ROP) and/or dense granules (GRA). Furthermore, excreted-secreted antigens (ESA) from freshly egressed tachyzoites displayed inhibitory activity. Proteins from ESA preparations were separated by a two-step fractionation using ion exchange chromatography followed size-exclusion chromatography, and analyzed by tandem mass spectrometry (MS/MS). Database mining of the MS/MS results generated a list of possible candidates, the majority of which originated from secretory organelles.Although MHC-II expression was inhibited, low levels of MHC-II molecules were still detected in infected or lysate-treated cells. Experimental results argued that the first layer of transcriptional regulation has to be complemented by a post-translational layer of interference in the host cell endocytic pathway, involving the MHC-II associated invariant chain (Ii), and peptide editor H2-DM. Ii mRNA and protein levels were induced in T. gondii-infected cells, while MHC-II and H2-DM IFN-induced expression was down-regulated. Ii accumulated in infected cells from 20 hour post-infection until host cell lysis, mainly in the ER. In Ii KO cells, the absence of Ii restored the ability of infected bone marrow-derived dendritic cells to present a parasite antigen in the context of MHC-II, arguing that Ii acts as a dominant negative on MHC-II-restricted antigen presentation of endogenously acquired parasite antigens. Keys host proteases, namely legumain, and cathepsins L and S, and the acidification of endosomal compartments were modulated by the parasite, pointing toward a wider manipulation of the host endocytic pathway by T. gondii. Opposing expression patterns of Ii and H2-DM had a drastic effect in vivo not only on parasite dissemination towards lymphoid organs, CD4+ T cell activation, and IFNÎł production during acute infection, but also on cyst numbers and survival at the chronic phase of the infection. Altogether, these findings reveal a broader manipulation of host cell processes by T. gondii, and shed new light on the intricate interactions between intracellular pathogens and host cells, and their ability to subvert immune functions to establish successful infections.Le parasite protozoaire intracellulaire obligatoire Toxoplasma gondii, l'agent causant la toxoplasmose, est un pathogĂšne ubiquitaire capable d'infecter tout animal Ă  sang chaud. En dĂ©pit du fait que l'infection reste gĂ©nĂ©ralement asymptomatique chez les individus en bonne santĂ©, le parasite s'enkyste inĂ©vitablement. Il a Ă©tĂ© dĂ©montrĂ© que T. gondii est capable d'atteindre ce but en partie en interfĂ©rant avec la prĂ©sentation d'antigĂšne par le complexe majeur d'histocompatibilitĂ© (CMH)-II pour diminuer le dĂ©veloppement de la rĂ©ponse des cellules T CD4+ et pour ainsi devancer la rĂ©ponse adaptative du systĂšme immunitaire. Il a Ă©tĂ© dĂ©montrĂ© que T. gondii inhibe la transcription de CMH-II et autres gĂšnes liĂ©s, mais les molĂ©cules inhibitrices causatives restent inconnues.Pour identifier ces molĂ©cules, une stratĂ©gie pour un criblage gĂ©nĂ©tique avait Ă©tĂ© Ă©laborĂ©e. Une mutagĂ©nĂšse insertionelle Ă  travers le gĂ©nome devait ĂȘtre conduite pour perturber les gĂšnes codant pour ces molĂ©cules inhibitrices, suivie d'un tri par cytomĂ©trie en flux de cellules infectĂ©es avec des mutants. En isolant les mutants incapables d'inhiber l'expression de CMH-II, l'isolement des locus gĂ©nĂ©tiques et l'exploration des bases de donnĂ©es auraient pu permettre l'identification des molĂ©cules codĂ©es. Cependant, ce criblage ne fut complĂ©tĂ© dĂ» Ă  des limitations expĂ©rimentales. Des analyses biochimiques ont dĂ©montrĂ© que l'activitĂ© inhibitrice se retrouvait dans le surnageant d'haute-vitesse (HSS) prĂ©parĂ© Ă  partir de parasites soniquĂ©s, et Ă©tait enrichie avec des vitesses de centrifugation croissantes. L'activitĂ© inhibitrice Ă©tait dose-dĂ©pendante de protĂ©ines et Ă©tait complĂštement abrogĂ©e lorsque le SHV Ă©tait prĂ©alablement traitĂ© avec une protĂ©ase. Un fractionnement subcellulaire rĂ©vĂ©la que l'activitĂ© se retrouvait dans les fractions enrichies d'organelles sĂ©crĂ©toires (rhoptries et granules denses). Aussi, des antigĂšnes excrĂ©tĂ©s-sĂ©crĂ©tĂ©s (ESA) obtenus de tachyzoĂŻtes fraĂźchement lysĂ©s possĂ©daient une activitĂ© inhibitrice. Les protĂ©ines d'ESA furent sĂ©parĂ©es par fractionnement en deux Ă©tapes, commençant par une chromatographie par Ă©change d'ions, suivi par une chromatographie d'exclusion par taille et analysĂ©es par spectromĂ©trie de masse en tandem (MS/MS). Les rĂ©sultats obtenus furent comparĂ©s aux bases de donnĂ©es, et une liste fut dressĂ©e avec de candidats potentiels, la majoritĂ© d'entre eux provenant d'organelles de sĂ©crĂ©tion.MalgrĂ© l'expression rĂ©duite, quelques molĂ©cules de CMH-II Ă©taient dĂ©tectĂ©s dans les cellules infectĂ©es ou traitĂ©es. Nos rĂ©sultats dĂ©montrent que la rĂ©gulation transcriptionelle doit ĂȘtre complĂ©mentĂ©e par une interfĂ©rence au niveau post-traductionel dans la voie endocytique de la cellule hĂŽte qui implique la chaĂźne invariante associĂ©e au CMH-II (Ii) et l'Ă©diteur de peptide H2-DM. Les niveaux d'ARNm et de protĂ©ines d'Ii Ă©taient induits dans les cellules infectĂ©es, alors que ceux de CMH-II et d'H2-DM Ă©taient inhibĂ©s. Ii s'accumulait dans les cellules infectĂ©es dĂšs 20 heures post-infection, principalement dans le RE. Dans les cellules Ii KO, l'absence d'Ii rĂ©tablit la capacitĂ© de cellules dendritiques Ă  prĂ©senter un antigĂšne du parasite dans le contexte de CMH-II, proposant ainsi qu'Ii agit comme un dominant nĂ©gatif sur la prĂ©sentation d'antigĂšnes endogĂšnes provenant du parasite. Des protĂ©ases de l'hĂŽte (lĂ©gumaine, cathepsines L et S) et l'acidification des compartiments endosomaux Ă©taient modulĂ©es par le parasite, rĂ©vĂ©lant une manipulation plus Ă©tendue de la voie endocytique. Les modes d'expression opposĂ©s d'Ii et H2-DM avaient un effet in vivo sur la dissĂ©mination des parasites vers des organes lymphoĂŻdes, l'activation des cellules T CD4+, la production d'IFN, le nombre de kystes et la survie. Collectivement, nos rĂ©sultats montrent l'Ă©tendue des processus de manipulation par T. gondii, rĂ©vĂ©lant de complexes interactions avec l'hĂŽte et sa capacitĂ© de subvertir les fonctions immunitaires pour Ă©tablir une infection chronique

    Spondylodiscitis Due to Clostridium ramosum Infection in an Immunocompetent Elderly Patient

    No full text
    The first ever case of spondylodiscitis caused by Clostridium ramosum in an elderly immunocompetent patient has been reported. C. ramosum is usually an intestinal bacterium but may occasionally be isolated in clinical specimens as an opportunistic pathogen. This report shows that this anaerobic organism can cause bone tropism without there having been any contamination due to spinal surgery. The infection cleared after empirical therapy using intravenous amoxicillin and oral metronidazole
    • 

    corecore